DepoDur, which was developed by and licensed from Pacira Pharmaceuticals, utilizes Pacira’s DepoFoam technology and is a novel, single dose modified-release formulation of morphine.
The approved indication in Australia is for the relief of post-operative pain, following major orthopedic, abdominal or pelvic surgery via the lumbar epidural route, without the restrictions and potential complications associated with an indwelling epidural catheter, at a maximum recommended dose of 10mg.
DepoDur will be available in Australia from February 2008.